ADRB2 and type 2 diabetes mellitus: Given these effects in young, healthy volunteers, it is tempting to postulate that prolonged treatment with a selective β2-AR agonist also has the potential to have a marked beneficial effect on insulin sensitivity in volunteers with disturbed glucose homeostasis, such as in T2DM patients.